Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand

• Hauptverfasser: Pinyo Rattanaumpawan (Verfasst von), Supunnee Jirajariyavej (Verfasst von), Kanokorn Lerdlamyong (Verfasst von), Nattawan Palavutitotai (Verfasst von), Jatuporn Saiyarin (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2022-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Favipiravir is a broad-spectrum oral antiviral agent that shows in vitro activity against SARS-CoV-2. Presently, data on the real-world effectiveness and optimal dosage of favipiravir for treating COVID-19 are limited. We conducted a retrospective observational study of hospitalized adult patients w...